Apr 22, 2022 by Kody KesterWarren Buffett Hates Managing Rentals, but Loves This Other Money-Making Real Estate InvestmentSTORE Capital is the only real estate investment trust in Berkshire Hathaway's investment portfolio.
Apr 22, 2022 by Kody KesterIs It Time to Buy This Beaten-Down Growth Stock?The Nasdaq Composite correction and near-term inflationary concerns have weighed on Starbucks' stock price this year.
Apr 20, 2022 by Kody Kester2 Healthcare Stocks That Could Make You RicherThese companies should benefit from steadily growing demand for their products and services.
Apr 20, 2022 by Kody KesterDown 19%, Is Digital Realty Trust Still a Buy?The real estate investment trust is a dominant player in the growing data center industry.
Apr 20, 2022 by Kody KesterAbbVie Snags Another Regulatory Approval for This Blockbuster DrugThe company's immunology drug Rinvoq was given the go-ahead to treat adult patients with moderate-to-severe ulcerative colitis.
Apr 16, 2022 by Kody Kester2 Top Healthcare Stocks to Buy Right NowThese stocks operate in different parts of the global healthcare industry.
Apr 15, 2022 by Kody KesterWant $1,000 in Annual Income? These 2 Sizzling Stocks Are BuysThese two real estate investment trusts throw off steady and significant dividend income.
Apr 14, 2022 by Kody KesterHere's What This Regulatory News Could Mean for GlaxoSmithKlineGlaxoSmithKline's anemia of chronic kidney disease drug could be just months away from authorization in the European Union.
Apr 14, 2022 by Kody KesterIs This Fast-Growing Retailer a Buy Following Its Dividend Hike?Williams-Sonoma rewarded shareholders by announcing a healthy raise in its payout and a new, large share-repurchase program.
Apr 14, 2022 by Kody Kester3 Dividend Stocks You Can Buy TodayThese dividend stocks offer investors market-beating payouts.
Apr 13, 2022 by Kody Kester2 Top Warren Buffett Stocks to Buy Right NowThese two dividend growth stocks can be found in the Oracle of Omaha's portfolio.
Apr 9, 2022 by Kody KesterCould This Drug Candidate Be a Blockbuster for Sanofi?The pharma giant recently shared encouraging results from a late-stage clinical trial for its hemophilia drug candidate.
Apr 8, 2022 by Kody Kester4 Reasons to Buy This Blue-Chip StockThis health insurer is one of the largest and most well-established in the world.
Apr 8, 2022 by Kody KesterThis Unofficial Dividend King Is a Great Stock for Income InvestorsLeggett & Platt flies under the radar for most dividend investors. But it shouldn't.
Apr 8, 2022 by Kody KesterIs This Under-the-Radar Growth Stock a Buy?This genetic diagnostics company could be a good pick for growth investors.
Apr 7, 2022 by Kody Kester2 Dividend Stocks That Will Pay You for LifeThese dividend stocks can provide investors with a steady income.
Apr 6, 2022 by Kody KesterGot $1,000? 2 Unstoppable Real Estate Trends That Could Make You RicherData centers and telecom towers are two steadily growing industries.
Apr 6, 2022 by Kody Kester1 Growth Stock You Can Buy for Less Than $100The company is the leader of the growing pet health insurance industry.
Apr 5, 2022 by Kody KesterWhat This Regulatory Approval Could Mean for MerckJapan has approved cancer drug Keytruda's pairing with another drug to treat certain kidney cancer patients.
Apr 2, 2022 by Kody KesterIs This Overlooked Stock a Buy After Its Dividend Hike?LeMaitre Vascular could be a hidden gem for dividend growth investors.
